Clinical trial

Safety and Immunogenicity of Recombinant HIV Vaccines for HIV/AIDS

NCT01881581

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2013-06-01

PhasePHASE1

Study timeline

Study start (unknown)2013-06-01Date precision: month

Registry last updated2013-06-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Acquired Immunodeficiency Syndromeunresolved

Interventions

Saline SolutionBIOLOGICAL

D-GPEiBIOLOGICAL

M-GPEBIOLOGICAL

Sponsors & collaborators

Centers for Disease Control and Prevention, Chinalead sponsor

Beijing Ditan Hospitalcollaborator

National Institutes for Food and Drug Control, Chinacollaborator

Mapped research locations

BeijingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01881581 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.